This incomplete inhibitory effect is sufficient to reduce the endothelial adhesion and spontaneous metastasis of tumor cells/xenografts lacking the canonical E-selectin ligands sLeA and sLeX but is obviously insufficient to reduce the adhesion and metastasis of sLeA/X-positive tumors that are characterized by marked E-selectin binding affinity. The gene discussed is SELE; the disease is neoplasm.